Hillman Capital
Q2 2026 versus Q1 2026: 3 bought, 14 added to, 35 reduced, 5 sold. By dollars, the largest buy was DuPont, $5.1M more at the quarter-end price; the largest sale DuPont, $5.4M less. Net, $11.4M more sold than bought. What every tracked investor did in Q2 2026.
Every move, largest first
| Ticker | Issuer | Move | Shares Q1 2026 → Q2 2026 | Bought / sold | Of the portfolio | Weight now | Price vs model |
|---|---|---|---|---|---|---|---|
| DD | Dupont de Nemours INC | sold | 39,300.3 → 0 | −$5.4M | −3.91% | — | — |
| DD | Dupont de Nemours INC | bought | — → 37,745 | +$5.1M | +3.71% | 3.7% | 443% overvalued |
| TROW | Price T Rowe Group INC | reduced −86% | 25,902 → 3,610 | −$2.5M | −1.83% | 0.3% | 36% undervalued |
| VEEV | Veeva Sys INC | bought | — → 14,008 | +$2.5M | +1.80% | 1.8% | 157% overvalued |
| CVS | Cvs Health Corp | reduced −18% | 67,462 → 55,475 | −$1.2M | −0.90% | 4.2% | 420% overvalued |
| BIIB | Biogen INC | reduced −19% | 29,540 → 23,993 | −$1.2M | −0.87% | 3.8% | 34% undervalued |
| TSM | Taiwan Semiconductor Manufac | reduced −30% | 7,962 → 5,608 | −$1.1M | −0.81% | 1.9% | — |
| KMX | Carmax INC | reduced −16% | 109,181 → 91,385 | −$941,230.5 | −0.68% | 3.5% | — |
| UNH | Unitedhealth Group INC | reduced −27% | 7,405 → 5,405 | −$831,259.9 | −0.60% | 1.6% | 19% overvalued |
| IFF | International Flavors&fragra | reduced −14% | 72,773 → 62,875 | −$784,119.6 | −0.57% | 3.6% | 22% overvalued |
| AKAM | Akamai Technologies INC | reduced −28% | 22,825 → 16,387 | −$761,035.9 | −0.55% | 1.4% | 11% undervalued |
| USB | Us Bancorp | reduced −21% | 52,528 → 41,252 | −$681,070.5 | −0.49% | 1.8% | 10% undervalued |
| ORCL | Oracle Corp | reduced −29% | 16,109 → 11,496 | −$676,035.2 | −0.49% | 1.2% | 30% undervalued |
| WST | West Pharmaceutical Svsc INC | reduced −20% | 8,906 → 7,106 | −$646,200 | −0.47% | 1.8% | 244% overvalued |
| BMY | Bristol-myers Squibb CO | reduced −15% | 53,102 → 45,235 | −$453,296.6 | −0.33% | 1.9% | 43% undervalued |
| CAG | Conagra Brands INC | added +22% | 147,639 → 180,728 | +$445,378 | +0.32% | 1.8% | — |
| STZ | Constellation Brands INC | reduced −17% | 18,795 → 15,651 | −$437,299 | −0.32% | 1.6% | 5% overvalued |
| CRM | Salesforce INC | added +25% | 10,956 → 13,658 | +$423,295.3 | +0.31% | 1.5% | 37% overvalued |
| ACN | Accenture PLC Ireland | bought | — → 3,055 | +$380,164 | +0.28% | 0.3% | 13% undervalued |
| GE | Ge Aerospace | sold | 1,282 → 0 | −$363,793 | −0.26% | — | — |
| SPYM | Spdr Series Trust | sold | 4,444 → 0 | −$340,144 | −0.25% | — | — |
| VZ | Verizon Communications INC | reduced −12% | 64,998 → 57,263 | −$327,499.8 | −0.24% | 1.8% | 67% undervalued |
| PFE | Pfizer INC | reduced −7% | 187,937 → 174,610 | −$320,914.2 | −0.23% | 3.0% | 3% undervalued |
| GSK | Gsk PLC | reduced −5% | 97,432 → 92,383 | −$264,668.6 | −0.19% | 3.5% | — |
| IVV | Ishares Tr | added +27% | 1,250 → 1,589 | +$253,873.7 | +0.18% | 0.9% | — |
| BAX | Baxter Intl INC | reduced −5% | 247,320 → 236,032 | −$240,660.1 | −0.17% | 3.6% | 35% overvalued |
| IGOV | Ishares Tr | sold | 5,608 → 0 | −$230,264 | −0.17% | — | — |
| BWX | Spdr Series Trust | sold | 10,384 → 0 | −$227,929 | −0.16% | — | — |
| ADBE | Adobe INC | added +7% | 16,200 → 17,288 | +$223,061.8 | +0.16% | 2.6% | 28% undervalued |
| MSFT | Microsoft Corp | reduced −5% | 10,828 → 10,296 | −$198,446.6 | −0.14% | 2.8% | 10% overvalued |
| WBD | Warner Bros Discovery INC | reduced −3% | 196,309 → 189,986 | −$168,571.2 | −0.12% | 3.7% | 137% overvalued |
| BA | Boeing CO | reduced −3% | 22,326 → 21,574 | −$162,785.4 | −0.12% | 3.4% | 123% overvalued |
| EFX | Equifax INC | reduced −7% | 13,556 → 12,541 | −$161,100.8 | −0.12% | 1.4% | 39% overvalued |
| MDT | Medtronic PLC | added +56% | 3,668 → 5,707 | +$159,511.1 | +0.12% | 0.3% | 4% overvalued |
| BDX | Becton Dickinson & CO | added +7% | 14,209 → 15,238 | +$155,718.6 | +0.11% | 1.7% | 14% undervalued |
| EL | Lauder Estee Cos INC | reduced −4% | 52,172 → 50,226 | −$153,636.7 | −0.11% | 2.9% | 1731% overvalued |
| ZBH | Zimmer Biomet Holdings INC | reduced −3% | 55,700 → 53,943 | −$151,260.1 | −0.11% | 3.4% | 44% undervalued |
| CMCSA | Comcast Corp New | added +6% | 95,228 → 100,843 | +$137,848.3 | +0.10% | 1.8% | 83% undervalued |
| CPB | The Campbells Company | reduced −3% | 166,178 → 161,043 | −$114,356.5 | −0.08% | 2.6% | — |
| FISV | Fiserv INC | reduced −3% | 80,728 → 78,456 | −$111,441.6 | −0.08% | 2.8% | 83% undervalued |
| KHC | Kraft Heinz CO | reduced −2% | 201,140 → 196,494 | −$109,738.5 | −0.08% | 3.4% | 39% overvalued |
| BF/B | Brown Forman Corp | reduced −2% | 176,437 → 172,514 | −$104,547.9 | −0.08% | 3.3% | 9% undervalued |
| EFA | Ishares Tr | added +3% | 30,854 → 31,743 | +$92,349.6 | +0.07% | 2.4% | — |
| DIS | Disney Walt CO | added +3% | 24,599 → 25,385 | +$75,652.5 | +0.05% | 1.8% | 9% undervalued |
| INTU | Intuit | added +26% | 957 → 1,203 | +$64,206 | +0.05% | 0.2% | 24% undervalued |
| CSGP | Costar Group INC | added +26% | 8,557 → 10,745 | +$61,964.1 | +0.04% | 0.2% | 94% overvalued |
| IWR | Ishares Tr | reduced −18% | 2,449 → 2,007 | −$48,771.1 | −0.04% | 0.2% | — |
| TMO | Thermo Fisher Scientific INC | added +14% | 656 → 750 | +$47,127.8 | +0.03% | 0.3% | 78% overvalued |
| GOOG | Alphabet INC | reduced −9% | 1,127 → 1,030 | −$34,273 | −0.02% | 0.3% | 49% overvalued |
| NKE | Nike INC | added +0% | 77,906 → 78,213 | +$12,602.4 | +0.01% | 2.3% | 16% overvalued |
| APD | Air Products And Chemicals I | reduced −2% | 1,339 → 1,306 | −$9,674.9 | −0.01% | 0.3% | 9% overvalued |
| RTX | Rtx Corporation | reduced −2% | 1,975 → 1,935 | −$7,589.2 | −0.01% | 0.3% | 9% overvalued |
| BLK | Blackrock INC | reduced −1% | 347 → 343 | −$3,846.2 | −0.00% | 0.2% | 23% overvalued |
| NOW | Servicenow INC | added +1% | 3,377 → 3,415 | +$3,772.6 | +0.00% | 0.2% | 264% overvalued |
| CLX | Clorox CO Del | reduced −1% | 3,555 → 3,531 | −$2,290.6 | −0.00% | 0.2% | 39% undervalued |
| DEO | Diageo PLC | reduced −0% | 27,507 → 27,492 | −$1,205.7 | −0.00% | 1.6% | — |
| GOOGL | Alphabet INC | reduced −33% | 6 → 4 | −$714.5 | −0.00% | 0.0% | 51% overvalued |
Bought / sold is the change in shares × the quarter's reported price (value ÷ shares in the filing); a position sold out is priced at the quarter before, since it has no price in this one. “Of the portfolio” is that amount against this quarter's reported book.
Source: the manager's Form 13F-HR on SEC EDGAR, kept as immutable quarterly snapshots; changes compare two consecutive filings. A 13F is filed up to 45 days after quarter end and covers US-listed long positions only. Tickers come from a self-maintained CUSIP map; a position without one shows its CUSIP. Method notes in where the numbers come from.